Back
Invesco S&P 500® Equal Weight Fincl ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
50
RSPF
Invesco S&P 500® Equal Weight Fincl ETF
Last Price:
70.00
Seasonality Move:
4.44%
Buy
70
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
50
Invesco S&P 500® Equal Weight Fincl ETF (RSPF)
is a Sell
Is Invesco S&P 500® Equal Weight Fincl ETF a Buy, Sell or Hold?
- The current Invesco S&P 500® Equal Weight Fincl ETF [RSPF] share price is $70.22. The Score for RSPF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RSPF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $331.32. The Score for MDGL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RSPF Stock Price Chart
What is Invesco S&P 500® Equal Weight Fincl ETF's stock price today?
-
The Invesco S&P 500® Equal Weight Fincl ETF share price today is $70.22
The current trend is moderately bearish and RSPF is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $331.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
RSPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.48 | Buy |
Relative Strength Index (14 RSI): | 47.48 | Sell |
Chaikin Money Flow: | 1570 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (69.45 - 71.97) | Sell |
Bollinger Bands (100): | (63 - 69.96) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.42 | Buy |
Relative Strength Index (14 RSI): | 86.69 | Buy |
Chaikin Money Flow: | 576514 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (190.5 - 254.66) | Buy |
Bollinger Bands (100): | (221.16 - 280.26) | Buy |
RSPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.19 | Sell |
20-day SMA: | 71.18 | Sell |
50-day SMA: | 69.45 | Buy |
200-day SMA: | 63.87 | Buy |
8-day EMA: | 71 | Sell |
20-day EMA: | 70.84 | Sell |
50-day EMA: | 69.37 | Buy |
200-day EMA: | 64.22 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 246.83 | Buy |
20-day SMA: | 225.95 | Buy |
50-day SMA: | 229.96 | Buy |
200-day SMA: | 241.65 | Buy |
8-day EMA: | 263.88 | Buy |
20-day EMA: | 237.89 | Buy |
50-day EMA: | 234.01 | Buy |
200-day EMA: | 235.45 | Buy |
Invesco S&P 500® Equal Weight Fincl ETF Earnings Growth & RSPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
Invesco S&P 500® Equal Weight Fincl ETF Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |